OVERVIEW
Real-time continuous glucose monitoring (rtCGM) devices provide important advances in blood glucose monitoring technology, facilitating recognition of patient-specific trends of hyper- and hypoglycemia. rtCGM is now being evaluated and utilized in a variety of settings and conditions, including primary care, outpatient, and in-hospital settings, and in conditions such as type 1 diabetes, type 2 diabetes, and pregnancy. Join our diabetes experts as they discuss the evolution and increasing role of CGM in the hospital, in type 2 diabetes, and pregnancy. The 90-minute live symposium will also be simultaneously streamed live for online attendees, who will have an opportunity to participate in a 2-way conversation with faculty. Attendees will be able to ask questions related to the content to the faculty in both settings.
Enhance Your Virtual Experience With Backstage Pass!
Join our 30-minute post-symposium breakout session connecting the program speakers and audience in the virtual environment. Backstage Pass provides an intimate virtual session where you can interact with faculty, address case-based questions, and facilitate relationship building.
*Video Encouraged*
TARGET AUDIENCE
This activity is intended for attendees of the American Diabetes Association’s (ADA) 83rd Scientific Sessions and others not attending ADA, including diabetologists & endocrinologists, primary care physicians, obstetricians and gynecologists, nurses, nurse practitioners, physician assistants, pharmacists, and other clinicians involved in the management of patients with diabetes.
GOAL STATEMENT
The goal of this activity is for learners to be better able to use real-time continuous glucose monitoring (rtCGM) in clinical practice.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the [LIST][ITEM]Data supporting rtCGM use for patients with diabetes [/LIST]Have greater competence related to [LIST][ITEM]Use of rtCGM in various patients with diabetes [/LIST]Demonstrate greater confidence in their ability to [LIST][ITEM]Use data from rtCGM to improve the management of diabetes
ACCREDITATION STATEMENT
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO] [MEDSCAPE]
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.5 [italic][bold]AMA PRA Category 1 Credit(s)™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses[/bold] Awarded 1.50 contact hour(s) of nursing continuing professional development for RNs and APNs. [bold]For Pharmacists[/bold] Medscape designates this continuing education activity for 1.50 contact hour(s) (0.150 CEUs) (Universal Activity Number: JA0007105-0000-23-120-L01-P).
Hilton San Diego Bayfront
Room: Indigo AE (Level 2)
1 Park Boulevard
San Diego, CA 92101
Supported by an independent educational grant from [bold]Dexcom[/bold]